Chinese Academy of Sciences;Guangzhou Institute of Biomedicine and Health
发明人:
Zhou, Xi,Ding, Ke,Kang, Zhanfang,Wong, Chiwai
申请号：
AU2009225171
公开号：
AU2009225171C1
申请日:
2009.03.05
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
The compounds according to formula (I), their pharmaceutically acceptable acid or base addition salts, and the uses thereof. These compounds and their pharmaceutically acceptable acid or base addition salts can be used for the preparing a medicament for modulating estrogen related receptors (ERR), and treating metabolic diseases, such as high blood fat, fatty liver, hyperglycemia, diabetes, fat. The definition of the groups of the formula is defined as the description.
